Differential Diagnosis
DDx Strength: Weak
cabozantinib, Multiple skin lesions Add or remove findings

Xerosis

XerosisXerosis

Acral erythema

Acral erythemaAcral erythema

Drug-induced hypopigmentation

Drug-induced hypopigmentationDrug-induced hypopigmentation

Drug-induced skin ulcers

Drug-induced skin ulcersDrug-induced skin ulcers

Toxic erythema of chemotherapy

Toxic erythema of chemotherapy

Drug-induced abdominal pain

Drug-induced abdominal pain

Drug-induced cough

Drug-induced cough

Drug-induced diarrhea

Drug-induced diarrhea

Drug-induced dyspepsia

Drug-induced dyspepsia

Drug-induced nausea or vomiting

Drug-induced nausea or vomiting

Chemotherapy-induced mucositis

Chemotherapy-induced mucositisChemotherapy-induced mucositis

Drug-induced alopecia

Drug-induced alopeciaDrug-induced alopecia

Drug-induced anorexia

Drug-induced anorexia

Drug-induced constipation

Drug-induced constipation

Drug-induced fatigue

Drug-induced fatigue

Drug-induced hypertension

Drug-induced hypertension

Drug-induced weight loss

Drug-induced weight loss

GI bleeding

GI bleeding

Hyperbilirubinemia

HyperbilirubinemiaHyperbilirubinemia

Hypocalcemia

Hypocalcemia

Hypokalemia

Hypokalemia

Hyponatremia

Hyponatremia

Peripheral neuropathy

Peripheral neuropathy

Bowel perforation

Bowel perforationBowel perforation

Drug-induced weakness

Drug-induced weakness

Reversible posterior leukoencephalopathy syndrome

Reversible posterior leukoencephalopathy syndrome

Drug-induced hemoptysis

Drug-induced hemoptysis